CEO Albert Bourla discusses Pfizer’s eight-month race to develop a COVID-19 vaccine, which he thinks will be available to frontline workers in December and the general public before the summer. He talks about efficacy, safety and distribution.
Save my name, email, and website in this browser for the next time I comment.